DULCOLAX

This brand name is authorized in United States. It is also authorized in Australia, Austria, Brazil, Canada, Croatia, Cyprus, France, Hong Kong SAR China, Ireland, Malta, Mexico, Netherlands, New Zealand, Nigeria, Romania, Singapore, South Africa, UK.

Active ingredients

The drug DULCOLAX contains one active pharmaceutical ingredient (API):

1	Bisacodyl UNII 10X0709Y6I - BISACODYL
	Bisacodyl is a locally acting laxative from the diphenylmethane derivatives group having a dual action. As a contact laxative, for which also antiresorptive hydragogue effects have been described, bisacodyl stimulates after hydrolysis in the large intestine, the mucosa of both the large intestine and of the rectum. Stimulation of the mucosa of the large intestine results in colonic peristalsis with promotion of accumulation of water, and consequently electrolytes, in the colonic lumen. This results in a stimulation of defecation, reduction of transit time and softening of the stool. Stimulation of the rectum causes increased motility and a feeling of rectal fullness. The rectal effect may help to restore the “call to stool” although its clinical relevance remains to be established.
	Read more about Bisacodyl

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
DULCOLAX Gastro-resistant tablets	MPI, EU: SmPC	Medicines & Healthcare Products Regulatory Agency (GB)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
A06AB02	Bisacodyl	A Alimentary tract and metabolism → A06 Laxatives → A06A Laxatives → A06AB Contact laxatives
Discover more medicines within A06AB02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
AU	Pharmaceutical Benefits Scheme	10578R, 1260H, 3250C
BR	Câmara de Regulação do Mercado de Medicamentos	576720050064617
CA	Health Products and Food Branch	00003875, 00254142, 02397854
FR	Base de données publique des médicaments	64835956, 65323898
GB	Medicines & Healthcare Products Regulatory Agency	107527, 135340, 135347, 19164, 30744, 30745
HK	Department of Health Drug Office	02708
HR	Agencija za lijekove i medicinske proizvode	HR-H-041405896, HR-H-827370838
MT	Medicines Authority	MA1470/00401, MA1470/00402, MA1470/00501
MX	Comisión Federal para la Protección contra Riesgos Sanitarios	47191
NG	Registered Drug Product Database	B4-1895
Switch country to Nigeria in order to find specific presentations of DULCOLAX
NL	Z-Index G-Standaard, PRK	4960, 884
NZ	Medicines and Medical Devices Safety Authority	18027, 461, 463
RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	W68445001, W68446001
SG	Health Sciences Authority	02663P, 02668P, 02669P
US	FDA, National Drug Code	41167-0101, 41167-0200, 41167-0210, 41167-0290, 41167-0400
ZA	Health Products Regulatory Authority	E/11.5/531, E/11.5/532, E/11.5/534